MannKind Appoints James Shannon As Chairman

MannKind Corp. (MNKD) said that it appointed James Shannon as Chairman of the Board of Directors effective December 9, 2020.

The company noted that Kent Kresa, the former Chairman of the Board, will continue to serve on MannKind's Board and as Chair of the Compensation Committee of the Board.

Shannon served on the Board from February 2010 until April 2012 then rejoined the Board in May 2015. He served as the Chief Medical Officer for GlaxoSmithKline from 2012 - 2015 and prior to this, served as Global Head of Pharma Development for Novartis AG based in Basel, Switzerland.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Financial services firm Morgan Stanley (MS) reported Wednesday a profit for the fourth quarter that increased 10 percent from last year, reflecting 7 percent revenue growth amidst strength in Wealth Management and Investment Management business segments. Bank of America Corp. (BAC) reported Thursday that net income applicable to common shareholders for the fourth quarter grew 30 percent to $6.77 billion from last year's $5.21 billion, with earnings per share increasing to $0.82 from $0.59 in the prior year, reflecting strong operating leverage as revenues... Shares of ASML Holding N.V. were gaining more than 1 percent in Amsterdam trading after the Dutch semiconductor equipment maker reported Wednesday higher profit and net sales in its fourth quarter. The company also projects higher sales in fiscal 2022, and a 100 percent increase in total dividend.
Follow RTT